In the Literature: The Latest Research You Need to Know

Clinical question: Are elevated fasting blood glucose levels independently associated with poor outcomes in all types of acute coronary syndromes (ACS)?

Background: Elevated admission blood glucose levels have been associated with poor outcomes in ACS patients; however, the role of fasting blood glucose levels in these settings, especially non-ST elevation myocardial infarction (NSTEMI), is unclear. It also is uncertain if one is a better predictor of outcomes than the other.

Study design: Prospective cohort of 57,406 patients in the Global Registry of Acute Coronary Events (GRACE).

Setting: 106 hospitals located in 14 countries in North and South America, Europe, Australia, and New Zealand.

Synopsis: 22,001 admission and 13,526 fasting blood glucose levels were extracted from GRACE and categorized into groups ranging from <100 mg/dL to =300 mg/dL. Multivariate logistic regression analysis of the association between these and the primary outcomes of in-hospital and six-month post-discharge all-cause mortality was carried out.

Fasting glucose levels higher than 100 mg/dL were associated with a linear increase in inpatient mortality (irrespective of diagnosis of diabetes) with an eightfold increase at levels =300mg/dL (17.22% vs. 1.71%). Increased six-month mortality, especially in patients with NSTEMI and STEMI, was also noted. However, this was a nonlinear relationship due to a lower mortality at 200-299 mg/dL, possibly reflecting the higher number of diabetics undergoing treatment in this group.

Admission glucose levels showed a linear increase in inpatient mortality at levels higher than 126 mg/dL. In contrast to fasting levels, admission levels were not associated with poor long-term outcome.

Study limitations included the use of registry data from a subgroup analysis and the possibility that fasting glucose levels in severely ill patients might not be representative of actual metabolic state.

Bottom line: Elevated fasting blood glucose in patients with acute coronary syndromes may portend a worse outcome and may be a better predictor than admission glucose levels.

Citation: Sinnaeve PR, Steg PG, Fox KA, et al. Association of elevated fasting glucose with increased short-term and 6-month mortality in ST-segment elevation and non-ST-segment elevation acute coronary syndromes: the Global Registry of Acute Coronary Events. Arch Intern Med. 2009;169(4):401-409.

— Reviewed for “TH eWire” by Mital Patel, MD, Alraies Chadi, MD, Saurabh Kandpal, MD, Iqbal Masood, MD, Anuradha Ramaswamy, MD, Department of Hospital Medicine, Cleveland Clinic

Comment on this Article

Your email address will not be published. Required fields are marked *